Buy Rating Affirmed for Nemaura Medical on SugarBEAT Prospects and Market Expansion
Analysts Offer Insights on Healthcare Companies: Nemaura Medical (NMRD), Kineta (KA) and Regeneron (REGN)
HC Wainwright & Co. Maintains Buy on Nemaura Medical, Lowers Price Target to $2.5
Nemaura Medical Analyst Ratings
EF Hutton Adjusts Price Target on Nemaura Medical to $4 From $6, Maintains Buy Rating
EF Hutton Maintains Buy on Nemaura Medical, Lowers Price Target to $4
Nemaura Medical Analyst Ratings
Analysts' Top Healthcare Picks: Nemaura Medical (NMRD), Atreca (BCEL)
EF Hutton Reiterates Buy on Nemaura Medical, Maintains $6 Price Target
EF Hutton Sticks to Their Buy Rating for Nemaura Medical (NMRD)
EF Hutton Maintains Buy on Nemaura Medical, Maintains $6 Price Target
HC Wainwright Adjusts Price Target on Nemaura Medical to $7 From $8, Keeps Buy Rating
H.C. Wainwright Keeps Their Buy Rating on Nemaura Medical (NMRD)
HC Wainwright & Co. Maintains Buy on Nemaura Medical, Lowers Price Target to $7
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Catalyst Pharma (CPRX) and Nemaura Medical (NMRD)
No Data